Truist Financial Corp Alnylam Pharmaceuticals, Inc. Transaction History

Truist Financial Corp

$62.9 Billion
Q3 2024

A detailed history of Truist Financial Corp transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Truist Financial Corp holds 1,859 shares of ALNY stock, worth $458,801. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,859

Previous 1,728 7.58%

Holding current value

$458,801

Previous $419,000 21.96%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$233.81 - $287.01 $30,629 - $37,598	131 Added 7.58%	1,859 $511,000
Q2 2024 Aug 20, 2024	SELL	$143.31 - $247.0 $89,282 - $153,881	-623 Reduced 26.5%	1,728 $419,000
Q1 2024 May 10, 2024	SELL	$146.51 - $198.2 $18,606 - $25,171	-127 Reduced 5.13%	2,351 $351,000
Q4 2023 Feb 02, 2024	BUY	$151.41 - $196.57 $375,193 - $487,100	2,478 New	2,478 $474,000
Q1 2023 May 05, 2023	SELL	$182.66 - $235.53 $25,572 - $32,974	-140 Reduced 9.54%	1,328 $266,000
Q4 2022 Feb 17, 2023	BUY	$185.53 - $241.31 $272,358 - $354,243	1,468 New	1,468 $348,000
Q2 2022 Jul 22, 2022	SELL	$120.42 - $169.29 $231,688 - $325,713	-1,924 Reduced 27.79%	5,000 $729,000
Q1 2022 Apr 22, 2022	SELL	$127.18 - $173.91 $85,337 - $116,693	-671 Reduced 8.83%	6,924 $1.13 Million
Q4 2021 Feb 14, 2022	BUY	$159.56 - $209.29 $158,283 - $207,615	992 Added 15.02%	7,595 $1.29 Million
Q3 2021 Nov 05, 2021	BUY	$169.75 - $207.73 $6,790 - $8,309	40 Added 0.61%	6,603 $1.25 Million
Q2 2021 Aug 16, 2021	BUY	$128.63 - $176.89 $107,791 - $148,233	838 Added 14.64%	6,563 $1.11 Million
Q1 2021 May 17, 2021	BUY	$126.83 - $175.69 $503,768 - $697,840	3,972 Added 226.58%	5,725 $808,000
Q4 2020 Nov 19, 2021	SELL	$122.97 - $147.0 $513,153 - $613,431	-4,173 Reduced 70.42%	1,753 $228,000
Q4 2020 Feb 18, 2021	BUY	$122.97 - $147.0 $559,144 - $668,409	4,547 Added 329.73%	5,926 $771,000
Q3 2020 Nov 13, 2020	SELL	$121.19 - $165.49 $47,264 - $64,541	-390 Reduced 22.05%	1,379 $201,000
Q2 2020 Aug 14, 2020	SELL	$104.21 - $156.44 $17,507 - $26,281	-168 Reduced 8.67%	1,769 $262,000
Q1 2020 May 15, 2020	SELL	$93.12 - $133.99 $18,717 - $26,931	-201 Reduced 9.4%	1,937 $211,000
Q4 2019 Feb 14, 2020	BUY	$74.51 - $124.23 $159,302 - $265,603	2,138 New	2,138 $245,000

Others Institutions Holding ALNY

# of Institutions

642

Shares Held

109M

Call Options Held

1.28M

Put Options Held

1.21M

View Full List

About ALNYLAM PHARMACEUTICALS, INC.

Ticker ALNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 123,028,000
Market Cap $30.4B
Description
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...

More about ALNY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Truist Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Truist Financial Corp with notifications on news.

Account

Truist Financial Corp Alnylam Pharmaceuticals, Inc. Transaction History